Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05162820 · ClinicalTrials.gov registry record · NA
Impact of Solarplast® on Immunity in Active Smokers and Non-smokers
A NA study, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05162820: Completed NA study, sponsored by University of Memphis.
NCT05162820 is a NA study that has completed, run by University of Memphis. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05162820, a NA study, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the impact of Solarplast treatment on measures of oxidative stress, immune function, skin appearance, and associated measures in 60 men and women, consisting of both cigarette smokers and nonsmokers. The hypothesis is that the Solarplast treatment will reduce oxidative stress biomarkers and favorably impact immune measures and both perceived and quantifiable measures of skin health, in both smokers and non-smokers, with a greater impact observed in smokers. Photographic analyses like the Pear Plus 3D system have been developed for clinical use for monitoring skin health.
Primary Outcome
Cytokines analyzed from plasma for IL-1beta, IL-6, IL-10, and TNF-alpha
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT 100 mg Solarplast
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2021-10-22 |
| Est. Completion | 2023-08-24 |
| Phase | NA |
What the finished NCT05162820 record still lists
NCT05162820 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT05162820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05162820 about?
NCT05162820 is a clinical study titled "Impact of Solarplast® on Immunity in Active Smokers and Non-smokers". The purpose of this study is to determine the impact of Solarplast treatment on measures of oxidative stress, immune function, skin appearance, and associated measures in 60 men and women, consisting of both cigarette smokers and nonsmokers. The hypothesis is that the Solarplast treatment will reduc...
What is the current status of trial NCT05162820?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2021-10-22. Estimated completion is 2023-08-24.
What interventions are being tested in trial NCT05162820?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 100 mg Solarplast (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05162820?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05162820's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI